English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Jamie Barrand | Feb 7, 2016

FDA to review Shire's second New Drug Application for dry eye therapy

Jamie Barrand | Feb 7, 2016

Mersana, Takeda partner on tumor therapy development

Jamie Barrand | Feb 5, 2016

Mind Your Risks campaign addresses link between high blood pressure, decreased brain function

Jamie Barrand | Feb 5, 2016

Spiriva Respimat approved in U.S. for asthma maintenance

Kasey Schefflin- Emrich | Feb 5, 2016

AbbVie's venetoclax cancer treatment receives FDA Breakthrough Therapy Designation

Jamie Barrand | Feb 5, 2016

CDC releases 2016 vaccination schedules for adults, children

Jamie Barrand | Feb 5, 2016

AHA study suggests increase in stroke risk for people over 60 with systolic blood pressure numbers above 140

Jamie Barrand | Feb 4, 2016

Collins, Klobuchar recommend increased funding for Alzheimer's research

Trending

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access

  • « First
  • «
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily